-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Biontech And Bristol Myers Squibb Report Encouraging Global Phase 2 Data For Pumitamig In Advanced Nsclc After Progression On Immunotherapy Plus Chemotherapy

Reuters·10/25/2026 07:31:21

Please log in to view news